Sun Pharmaceutical Industries informs about board meeting

13 May 2022 Evaluate

Sun Pharmaceutical Industries has informed that a meeting of the Board of Directors of the company is scheduled to be held on Monday, May 30, 2022: To approve Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022 and to recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2022 subject to approval of the shareholders at the ensuing Annual General Meeting. Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the trading window for trading in Company's shares by Designated Persons has been closed from April 01, 2022 till June 01, 2022 after 48 hours of the declaration of financial results. This intimation is being made pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1634.40 2.75 (0.17%)
27-Jan-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1240.70
Cipla 1301.00
Zydus Lifesciences 889.60
Lupin 2137.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×